Aug 11, 2020
Children's Minnesota physician appointed inaugural holder of Pine Tree Apple Tennis Classic Endowed Chair in Cancer and Blood Disorders Research
Aug 11, 2020
Mesothelioma Victims Center is Open 24-7 to Make Certain a Person with Confirmed Mesothelioma Receives the Best Compensation Results and They Endorse Attorney Erik Karst of Karst von Oiste to Get the Financial Settlement Job Done
Jun 22, 2020
Lung Cancer Research Foundation Names Dr. Trudy Oliver to its Scientific Advisory Board
Jun 18, 2020
Natera Announces First Patient Enrollments in Both CIRCULATE-Japan and BESPOKE CRC Trials Using Signatera(TM) MRD Testing
Jun 18, 2020
ArcherDX Enters Collaboration with Bristol Myers Squibb to Apply Personalized Cancer Monitoring (PCM(TM)) to Clinical Research
Jun 15, 2020
Jazz Pharmaceuticals Announces U.S. FDA Accelerated Approval of Zepzelca(TM) (lurbinectedin) for the Treatment of Metastatic Small Cell Lung Cancer
Jun 10, 2020
Ryvu Therapeutics Reports First Quarter 2020 Financial Results
Jun 03, 2020
New Small Cell Lung Cancer Drug Accepted for TGA Evaluation Under Project Orbis
May 26, 2020
ArcherDX Announces Strategic Collaboration with AstraZeneca to Develop Personalized Cancer Monitoring (PCM) Assays for Minimal Residual Disease (MRD)
May 19, 2020
MESOTHELIOMA LAWYERS - Find a Qualified Mesothelioma Lawyer
May 19, 2020
Natera Announces New Data at ASCO Highlighting Utility of Personalized MRD Monitoring
May 18, 2020
Janssen Announces Phase 1 Results for Bispecific Antibody Amivantamab in the Treatment of Patients with Advanced Non-Small Cell Lung Cancer Harboring Exon 20 Insertion Mutations
May 11, 2020
Bionical Emas and Jazz Pharmaceuticals Enter into an Agreement for Expanded Access to Lurbinectedin in Relapsed Small Cell Lung Cancer in the United States
May 05, 2020
Libtayo® (cemiplimab) Shows Clinically-Meaningful and Durable Responses in Second-line Advanced Basal Cell Carcinoma
May 04, 2020
SciBase and Advanced Dermatology and Cosmetic Surgery Group Partner to Advance Skin Cancer Detection in US' Largest Dermatology Network
Apr 08, 2020
Sirnaomics Announces Positive Topline Results from Interim Analysis of Ongoing Phase II Clinical Trial Evaluating STP705 in Cutaneous Squamous Cell Carcinoma in situ (isSCC)
Apr 02, 2020
New Study Shows Benefit of Using Signatera(TM) Technology for Personalized Monitoring in Gastrointestinal Cancer
Mar 10, 2020
Sysmex Inostics' Updated SafeSEQ Breast Cancer Panel Advances Novel Clinical Uses of ctDNA Through Quantitative Testing
Mar 09, 2020
/DISREGARD RELEASE: Sysmex Inostics GmbH/
Mar 03, 2020
Rothman Orthopaedics Surgeon Specializing in Rare Bone and Soft Tissue Cancers to Lead Capital Health's Sarcoma and Orthopaedic Oncology Program